Quoin Pharmaceuticals Ebitda Over Time
| QNRX Stock | USD 0.59 0.03 4.84% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Quoin Pharmaceuticals Performance and Quoin Pharmaceuticals Correlation. Quoin |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Quoin Pharmaceuticals. If investors know Quoin will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Quoin Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.66) | Return On Assets (0.36) | Return On Equity (1.00) |
The market value of Quoin Pharmaceuticals is measured differently than its book value, which is the value of Quoin that is recorded on the company's balance sheet. Investors also form their own opinion of Quoin Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Quoin Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Quoin Pharmaceuticals' market value can be influenced by many factors that don't directly affect Quoin Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Quoin Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Quoin Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Quoin Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Ebitda Analysis
Compare Quoin Pharmaceuticals and related stocks such as BWV, PaxMedica, Common Stock, and Revelation Biosciences Ebitda Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVB | (3.6 K) | (3.6 K) | (3.6 K) | (3.6 K) | (3.6 K) | (3.6 K) | (3.6 K) | (3.6 K) | (3.6 K) | (3.6 K) | (145.5 K) | (11.9 M) | (10.8 M) | (95.2 K) | (100 K) |
| VRAX | (648.8 K) | (648.8 K) | (648.8 K) | (648.8 K) | (648.8 K) | (648.8 K) | (648.8 K) | (648.8 K) | (648.8 K) | (648.8 K) | (644.5 K) | (750) | (5.4 M) | (6.6 M) | (6.3 M) |
| NRBO | (267 K) | (267 K) | (267 K) | (267 K) | (267 K) | (6.1 M) | (14.7 M) | (33.1 M) | (23 M) | (19.1 M) | (29.7 M) | (15.2 M) | (11.4 M) | (15.9 M) | (16.7 M) |
| ALLR | (10.1 M) | (10.1 M) | (10.1 M) | (10.1 M) | (10.1 M) | (10.1 M) | (10.1 M) | (10.1 M) | (10.1 M) | (10.1 M) | (6 M) | (25.9 M) | (17.2 M) | (12.1 M) | (12.7 M) |
| BDRX | (3.8 M) | (3.8 M) | (3.8 M) | (4.3 M) | (7.4 M) | (9.4 M) | (5.3 M) | (10.6 M) | (10.7 M) | (10.3 M) | (22.2 M) | (5.7 M) | (7.4 M) | (7.2 M) | (7.5 M) |
| UNCY | (2 M) | (2 M) | (2 M) | (2 M) | (2 M) | (2 M) | (2 M) | (2 M) | (2 M) | (2 M) | (2 M) | (9 M) | (17.9 M) | (30.2 M) | (28.7 M) |
| CDIO | (598.5 K) | (598.5 K) | (598.5 K) | (598.5 K) | (598.5 K) | (598.5 K) | (598.5 K) | (598.5 K) | (598.5 K) | (598.5 K) | (598.5 K) | (604.4 K) | (4.6 M) | (1.5 M) | (1.6 M) |
Quoin Pharmaceuticals and related stocks such as BWV, PaxMedica, Common Stock, and Revelation Biosciences Ebitda description
My Equities
My Current Equities and Potential Positions
| Quoin Pharmaceuticals Ltd | QNRX |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | Israel |
| Exchange | NASDAQ Exchange |
USD 0.59
Additional Tools for Quoin Stock Analysis
When running Quoin Pharmaceuticals' price analysis, check to measure Quoin Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quoin Pharmaceuticals is operating at the current time. Most of Quoin Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Quoin Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quoin Pharmaceuticals' price. Additionally, you may evaluate how the addition of Quoin Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.